SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Martek Biosciences---- future biotech cash cow!
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Asymmetric who wrote (18)3/12/1996 8:18:00 AM
From: bill small   of 258
 
Peter,
to tell you the truth, Fri I thought we had started what would be
a 5 to 7 % correction. The pundits thought 10% but I see more
strength. We still may get 5 even 10%; it's incredible that its
been 5 years since a 10% drawback. I will not try to time it as
I learned long ago. Ride it out. Sure, try to make day to day
decisiond on individual trades based on market feel but don't sell
out wholesale.

Biotechs I own include Martek, Trinity, Biospherics, Somatogen,
Molecular Biosystems, Medimmune, Autoimmune, Amgen. Like but don't own
Arris, Vical.

Just got my Vishay Intertech package and company looks great; great
low PE buy. Can't imagine Kemet any better buy but will still check
it out. NEVER seen so many positive brokerage houses comments as
included in Vishay package.

best...........Bill
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News